WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s share price shot up 4.8% during trading on Tuesday . The company traded as high as $12.5850 and last traded at $12.5850. 2,049 shares were traded during mid-day trading, a decline of 97% from the average session volume of 70,663 shares. The stock had previously closed at $12.01.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of WuXi Biologics (Cayman) to a “hold” rating in a research note on Friday, August 28th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the company has an average rating of “Hold”.
Check Out Our Latest Stock Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Price Performance
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
See Also
- Five stocks we like better than WuXi Biologics (Cayman)
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
